Literature DB >> 32266486

Circular RNAs and their participation in stemness of cancer.

Francisco Alejandro Lagunas-Rangel1.   

Abstract

Circular RNAs (circRNA) are covalently closed single-stranded RNA molecules that act as important regulators of gene expression through different mechanisms. Meanwhile, cancer stem cells (CSCs) are a small subpopulation of cells, with properties similar to normal stem cells that arise during the development of cancer and support tumor growth, induce resistance to therapy, and are responsible for metastatic spread. Since the elimination of CSCs is an important goal of cancer treatment, the circRNAs that participate in regulating gene expression and signaling pathways linked to CSCs have aroused attention in recent years, especially because it has been suggested that these molecules may function as therapeutic targets and/or clinical biomarkers. Thus, the proposal of this work is to enumerate a series of circRNAs that have been shown to play a relevant role in CSCs and explain in detail the molecular regulatory mechanisms that they establish to perform that function.

Entities:  

Keywords:  Cancer stem cell; Self-renewal; Sphere formation assay; Tumor initiation assay; circRNA

Year:  2020        PMID: 32266486     DOI: 10.1007/s12032-020-01373-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  63 in total

1.  CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.

Authors:  Yunlong He; E Mingyan; Chunbo Wang; Guohui Liu; Manru Shi; Shuang Liu
Journal:  Int J Biol Macromol       Date:  2018-11-30       Impact factor: 6.953

2.  Hsa_circRNA_33287 promotes the osteogenic differentiation of maxillary sinus membrane stem cells via miR-214-3p/Runx3.

Authors:  Wei Peng; Shuangxi Zhu; Junlan Chen; Jin Wang; Qiong Rong; Songling Chen
Journal:  Biomed Pharmacother       Date:  2018-11-20       Impact factor: 6.529

3.  A Noncoding Regulatory RNAs Network Driven by Circ-CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma.

Authors:  Yanping Wei; Xin Chen; Chi Liang; Yan Ling; Xinwei Yang; Xiaofei Ye; Hailing Zhang; Pinghua Yang; Xiuliang Cui; Yibing Ren; Xianglei Xin; Hengyu Li; Ruoyu Wang; Wenjing Wang; Feng Jiang; Suiyi Liu; Jing Ding; Baohua Zhang; Liang Li; Hongyang Wang
Journal:  Hepatology       Date:  2019-08-11       Impact factor: 17.425

4.  Dysregulated Pseudogene HK2P1 May Contribute to Preeclampsia as a Competing Endogenous RNA for Hexokinase 2 by Impairing Decidualization.

Authors:  Hong Lv; Jing Tong; Jieqiong Yang; Shijian Lv; Wei-Ping Li; Cong Zhang; Zi-Jiang Chen
Journal:  Hypertension       Date:  2018-02-12       Impact factor: 10.190

5.  Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.

Authors:  Yajuan Xiao; Yunfei Li; Hua Tao; Brock Humphries; Aimin Li; Yiguo Jiang; Chengfeng Yang; Rongcheng Luo; Zhishan Wang
Journal:  Cancer Lett       Date:  2018-06-30       Impact factor: 8.679

6.  Withdrawn: circLgr4 drives colorectal tumorigenesis and invasion through Lgr4-targeting peptide.

Authors: 
Journal:  Int J Cancer       Date:  2021-11-25       Impact factor: 7.396

7.  circRNADb: A comprehensive database for human circular RNAs with protein-coding annotations.

Authors:  Xiaoping Chen; Ping Han; Tao Zhou; Xuejiang Guo; Xiaofeng Song; Yan Li
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

8.  Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation.

Authors:  Xiangyu Dai; Chao Chen; Qianlei Yang; Junchao Xue; Xiong Chen; Baofei Sun; Fei Luo; Xinlu Liu; Tian Xiao; Hui Xu; Qian Sun; Aihua Zhang; Qizhan Liu
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

9.  CircFunBase: a database for functional circular RNAs.

Authors:  Xianwen Meng; Dahui Hu; Peijing Zhang; Qi Chen; Ming Chen
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

10.  High impact of miRNA-4521 on FOXM1 expression in medulloblastoma.

Authors:  Daniel Senfter; Mahzeiar Samadaei; Robert M Mader; Johannes Gojo; Andreas Peyrl; Georg Krupitza; Marcel Kool; Martin Sill; Christine Haberler; Gerda Ricken; Thomas Czech; Irene Slavc; Sibylle Madlener
Journal:  Cell Death Dis       Date:  2019-09-20       Impact factor: 8.469

View more
  6 in total

Review 1.  SIRT7 in the aging process.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Cell Mol Life Sci       Date:  2022-05-18       Impact factor: 9.207

2.  Elevated Circular RNA PVT1 Promotes Eutopic Endometrial Cell Proliferation and Invasion of Adenomyosis via miR-145/Talin1 Axis.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Biomed Res Int       Date:  2021-02-27       Impact factor: 3.411

3.  circCDYL2, Overexpressed in Highly Migratory Colorectal Cancer Cells, Promotes Migration by Binding to Ezrin.

Authors:  Xiaomin Li; Jianjun Wang; Huaicheng Long; Weihao Lin; Haowei Wang; Yujia Chen; Qinzi Yuan; Xuenong Li
Journal:  Front Oncol       Date:  2021-08-17       Impact factor: 6.244

4.  Editorial: Emerging Roles of Circular RNAs in the Tumor: Functions and Potential Applications.

Authors:  Shanchun Guo; Lan Huang; Mingli Liu
Journal:  Front Cell Dev Biol       Date:  2022-01-31

5.  Mapping a Circular RNA-microRNA-mRNA-Signaling Regulatory Axis That Modulates Stemness Properties of Cancer Stem Cell Populations in Colorectal Cancer Spheroid Cells.

Authors:  Vimalan Rengganaten; Chiu-Jung Huang; Ping-Hsing Tsai; Mong-Lien Wang; Yi-Ping Yang; Yuan-Tzu Lan; Wen-Liang Fang; Shelly Soo; Hooi Tin Ong; Soon Keng Cheong; Kong Bung Choo; Shih-Hwa Chiou
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

6.  Role of hypoxia inducible factor-1 in cancer stem cells (Review).

Authors:  Qi Zhang; Zhenzhen Han; Yanbo Zhu; Jingcheng Chen; Wei Li
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.